drugset / Trial / NCT01150474

Postoperative Belladonna and Morphine Suppositories in Vaginal Surgery

NCT01150474 ↗

Phase 4 Completed 103 enrolled Kristina A. Butler
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Our primary aim is to determine whether the routine use of belladonna and morphine suppositories will improve pain control following vaginal surgery. Treatment will begin immediately following surgery and every 8 hours for 16 hours.

Timeline

Start
2011-01
Primary completion
2013-12
Completion
2013-12

Outcome

Missed primary endpoint

registry analysis (superiority or other test); Belladonna and Opium Suppositories vs Placebo Suppositories; p = 0.82; t-test, 2 sided NCT01150474 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Belladonna Unknown 16.2 mg Other
Subject opium Traditional medicine (herbal / TCM) 60 mg Other

Indications

No indication recorded.